Agilent Technologies Investor
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.
Estimated Revenue:
$1B to $10B
Funding Status:
IPO
Industry:
Biotechnology, Health Diagnostics, Life Science, Pharmaceutical
Last Funding Date:
2019-09-05
Acquisitions Number:
Made Acquisitions
Number Of Exists:
9
Technology:
Genetic Test & Molecular Diagnostics
Founded Date:
1999-01-01
Headquarters:
Santa Clara, California, United States
Total Funding:
500000000.0
Last Funding Type:
Post-IPO Debt
Employee Number:
10001+